Subscribe

Moving women’s health front and center.

We’re a venture capital firm investing in the future of women’s health, building upon our track record at RH Capital.

Learn how we’re driving change

Women’s healthcare is a trillion-dollar market opportunity with the power to transform economies and strengthen communities. Recent investments have surged, but there is still so much more that we can do to make care more accessible, affordable, and equitable.

At Foreground Capital, we’re on a mission to reimagine the future of women’s health.

We have over 50 years of combined experience across finance, clinical medicine, and venture capital. Our leadership team brings exceptional insight and unwavering dedication to advancing women’s health innovation.

Our portfolio includes dozens of groundbreaking companies transforming healthcare for more than half a million women across the country.

And we’re just getting started.

Join us in transforming care for millions — explore our mission and portfolio.

Investing in Women’s Health, Changing the Future

Women’s Health
Foreground invests in companies addressing conditions that affect women directly, differently, and disproportionately.

Health Segments
We invest broadly across health segments, from life sciences to digital health, services, and more.

Impact
Guided by our four core impact pillars — Transformative Innovation, Access, Affordability, and Systemic Change — we drive meaningful improvements in healthcare outcomes for women while delivering competitive financial returns.

Investing in Women’s Health, Changing the Future

Women’s Health
Impact

 

We invest broadly across health segments, from life sciences to digital health, services, and more.

 

See our vision in action

In the News

FemTech Insider: Foreground Capital: A New Chapter in Women’s Health Investing

Business Insider: Alice Zheng moved from med school to McKinsey to venture capital

Forbes: Investing In Women’s Health: Opportunities, Challenges, Changes

MedCity News: Investing in Reproductive Health Companies Post-Dobbs: A Moral and Strategic Imperative

As Seen In

Read More About Our Impact

Your Front Row Seat to Women’s Health Innovation

Join our email list to receive Foreground Capital’s updates, insights, and news.

* indicates required

Foreground Capital has built one of the world’s largest dedicated women’s health portfolio investing in early-stage companies that make care more accessible, affordable, and equitable.

Contact

Reach out to [email protected]
Download our media kit here>>

Linkedin-in

Copyright© 2024 FOREGROUND CAPITAL, All rights reserved | Privacy Policy

To be a part of our journey, enter your email address below.

* indicates required

Alice Zheng, MD
Partner

Alice Zheng has been a women’s health enthusiast throughout her career spanning global health, clinical medicine, and the private sector. She is currently a Co-founder and Partner at Foreground Capital. Previously, she was a Principal at Foreground’s precursor funds at RH Capital. At Foreground Capital, she continues to manage RH Capital funds and serves as a board director for Seven Starling and Millie and as a board observer for AOA and Eli Health. 

Previously, Alice was a women’s health practice leader and management consultant at McKinsey & Company, where she published foundational research on women’s health. Earlier in her career, she trained as a physician with a focus on women’s health and worked in global public health in East Africa and Asia.  She has also been a patient in many women’s health areas including infertility, abortion, and difficult pregnancies.  

Alice holds an MBA from Harvard Business School and MD/MPH from the University of Michigan, where she was a Dean’s Merit Scholar. Her profile has been featured in Business Insider, 30 under 40 Healthcare, Michigan Medicine and more.  She holds advising and mentoring roles with multiple women’s health accelerators and forums, including co-chair of the NYSE Women’s Health Summit, which was headlined by First Lady Dr. Jill Biden in 2024.

Why women’s health? 

“I’ve always been drawn to underserved women’s issues, from performing in the Vagina Monologues three times in college to working in rural African villages without running water or electricity to prevent and treat obstetric fistulas. I am now a mother of two and have been a patient myself in many women’s health areas I once aspired to specialize in. It is a long-standing personal and professional passion of mine to improve lives of women around the world.”

Stasia Obremskey
Managing Partner

Stasia Obremskey has been investing in women for her entire career, believing that the two most impactful things you can do for the world are to educate women and give them tools to manage their fertility.  She is currently a Co-founder and Managing Partner at Foreground Capital. Stasia co-founded and led Foreground’s precursor funds at RH Capital.  At Foreground Capital, she continues to manage RH Capital funds and serves as a board director for Cadence OTC and as a board observer for Vitra Labs, Contraline, Eli Health and YourChoice Therapeutics. 

Previously, Stasia worked with healthcare organizations in the US and Asia, where she joined management teams as the Chief Financial Officer to provide finance, accounting, and strategic planning expertise to startups, fast-growing companies, and non-profit organizations. She began her career in management consulting with Bain & Company and investment banking with Morgan Stanley & Co. 

She holds an MBA from Harvard Business School and holds a bachelor’s degree in Business Administration with a concentration in finance from the University of Notre Dame. In addition to her consulting work, she has extensive experience as a member of several nonprofit boards.

Why women’s health? 

“While women make up 50% of the population, they birth 100% of the population and yet their unique healthcare needs have been historically overlooked.  I’m passionate about finding innovations to reverse this trend and address the many areas in women’s health still looking for improved and new solutions.”

Elizabeth Bailey
Managing Partner

Elizabeth Bailey has over 20 years of experience in venture capital and supporting early-stage healthcare companies. She is currently a Co-founder and Managing Partner at Foreground Capital. Elizabeth co-founded and led Foreground’s precursor funds at RH Capital.  At Foreground Capital, she continues to manage RH Capital funds and serves as a board director for Raydiant Oximetry and Testmate Health, and as a board observer for Bloomlife, Cayaba, Mae and Twentyeight Health. 

Elizabeth was previously a Partner at Commons Capital, one of the first impact investment funds, where she managed the healthcare portfolio, including Claros Diagnostics (acquired by OPKO), CodeRyte (acquired by 3M), HistoRx (acquired by Genoptix), Medical Metrx Solutions (acquired by AIG) and TelaDoc (IPO: TDOC). 

She holds a Masters in Public Policy from Harvard Kennedy School and a BA from Brown University. Throughout her career, Elizabeth has been a strong advocate of the power of business to drive social change. In 2023, she was named a Trailblazing Leader in Women’s Health, and in 2024 Elizabeth received the inaugural FemForce Vanguard Award for her leadership in women’s health. 

Why women’s health? 

I think Maya Angelou said it best, “I’m interested in women’s health because I’m a woman. I’d be a darn fool not to be on my own side.”